US 12110343
Anti-plasma kallikrein antibodies
granted A61PA61P29/00A61P31/04
Quick answer
US patent 12110343 (Anti-plasma kallikrein antibodies) held by Takeda Pharmaceutical Company Limited expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P29/00, A61P31/04, A61P35/00, A61P43/00